Nexavar
Nexavar Official FDA information, side effects and uses.
Posted by Nexavar (Nexavar) on Sat, 28 Jul 2007 18:17:15 +0000
The primary objective of the study was to compare overall survival in patients administered Nexavar versus those administered placebo. Median overall survival was 10.7 months in Nexavar-treated patients compared to 7.9 months in those ...
Nexavar prolongs survival among Liver cancer patients
The findings of a clinical trial presented by doctors at the American Society of Clinical Oncology meeting in Chicago on Monday provided hope to the deadly liver cancer patients as Nexavar, a drug developed by Onyx Pharmaceuticals Inc. ...
Bayer And Onyx Submit Supplemental New Drug Application For ...
(Nasdaq: ONXX) today announced that a Supplemental New Drug Application (sNDA) for Nexavar(R) (sorafenib) tablets has been submitted to the US Food and Drug Administration (FDA) for the treatment of patients with hepatocellular ...
Nexavar (sorafenib) and HCC
Data presented today at the 43rd annual meeting of the American Society of Clinical Oncology (ASCO) has shown that Nexavar (sorafenib) tablets significantly extended overall survival (OS) in patients with advanced hepatocellular ...
Liver Cancer Patients May Have 44% Higher Survival Rate By Nexavar
Bayer HealthCare Pharmaceuticals Inc. and Onyx Pharmaceuticals, Inc. today announced that Nexavar tablets significantly extended overall survival in patients with hepatocellular carcinoma , or primary liver ... via Huliq.com.
